Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001659819-15-000001
Filing Date
2015-12-01
Accepted
2015-12-01 17:15:05
Documents
1
Effectiveness Date
2015-12-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10928
  Complete submission text file 0001659819-15-000001.txt   11993
Mailing Address 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA 19355 484-318-2988
Velicept Therapeutics, Inc. (Filer) CIK: 0001659819 (see all company filings)

EIN.: 473400632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-252193 | Film No.: 151263025